To highlight the importance of obstructive sleep apnea (OSA) as a significant contributor to co-morbid disease in obese children To describe the prevalence of OSA in overweight and obese children and adolescents To discuss the current evidence for cardiovascular, metabolic and neurocognitive dysfunction in children with obesity related OSA To illustrate the treatments strategies and their outcomes for OSA in obese children.